Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report-Reference-Cited by-同舟云学术

Tumor reduction after SARS‑CoV‑2 infection in a patient with lung cancer: A case report

Published:2024-02-22 Issue:4 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zhang Xiaoming¹,Chen Jingyu²,Sun Jie³,Gao Shuyue⁴,Zhao Feiyu⁴,Qian Niansong⁵

Affiliation:

1. Department of Oncology, Hainan Hospital of Chinese PLA General Hospital, Sanya, Hainan 572000, P.R. China

2. Department of College English, School of Languages and Communication Studies, Beijing Jiaotong University, Beijing 100044, P.R. China

3. Department of Oncology, Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100039, P.R. China

4. Department of Oncology, Graduate School of Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China

5. Department of Respiratory and Critical Care Medicine, Eighth Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100091, P.R. China

Publisher

Spandidos Publications

Reference24 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Emerging strategies for the treatment of small cell lung cancer: A review;Petty;JAMA Oncol,2023

3. Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer;Vokes;Ther Adv Med Oncol,2023

4. The intersection of COVID-19 and cancer: Signaling pathways and treatment implications;Zong;Mol Cancer,2021

5. Oncology during the COVID-19 pandemic: Challenges, dilemmas and the psychosocial impact on cancer patients;Tsamakis;Oncol Lett,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gefitinib;Reactions Weekly;2024-06-01